BioSpace News Archive

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced publication of data in a murine model of GM1 gangliosidosis (GM1) demonstrating that a single intracerebroventricular injection of an optimized adeno-associated virus (AAV) into the cerebral spinal fluid (CSF) resulted in significant expression of Beta-galactosidase (β-g

Codiak BioSciences, Inc., a clinical-stage company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, announced the pricing of its initial public offering of 5,500,000 shares of its common stock at a public offering price of $15.00 per share, for gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and offering expenses.

Aesculap, Inc., an industry leader in sterile processing and operating room solutions, is pleased to announce its strategic partnership with Ascendco Health, an emerging health tech company.

The American Academy of Family Physicians held elections for its board of directors this week at its annual Congress of Delegates, the organization’s governing body.

Breg, Inc., a leading provider of orthopedic products and services designed to elevate patient care, today announced that its board of directors has appointed Stuart F. Simpson to executive chairman. Mr. Simpson has a distinguished record of spearheading inno

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the Israeli Ministry of Health authorized the initiation of a proposed investigator-initiated Phase II clinical trial evaluating Allocetra TM in severe and critical COVID-19 patients. The planned COVID-19 study is a multi-center investigator-initiated, Phase II clinical trial. The trial is expected to recruit up to twenty-f

Milestone Scientific Inc. (NYSE American:MLSS ), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, today announced that it has been awarded a group purchasing agreement for the CompuFlo® Epidural System and CathCheck™ with Premier. Effective November 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-n

Advanced ICU Care , the nation’s leading provider of high-acuity telemedicine services, announced a large strategic telemedicine partnership with UAB Medicine, a nationally recognized leader in patient care, researc

Includes International Distribution Status, Professional Video Finalized, XPRIZE Contest Next Steps, Manufacturing and Signed Testing Partner Updates

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of its peer reviewed journal article, “Three-Year Results of the SONATA Pivotal Trial of Transcervical Fib